Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to diabetes mellitus and other diseases: part II

2013 ◽  
Vol 8 (4) ◽  
pp. 465-480 ◽  
Author(s):  
>Undurti Narasimha Das
Keyword(s):  
Diabetes Mellitus ◽  
Specific Reference ◽  
Clinical Implications

scholarly journals Endothelial dysfunction in diabetes mellitus: Molecular mechanisms and clinical implications

2010 ◽  
Vol 11 (1) ◽  
pp. 61-74 ◽  
Author(s):  
Corey E. Tabit ◽  
William B. Chung ◽  
Naomi M. Hamburg ◽  
Joseph A. Vita
Keyword(s):  
Diabetes Mellitus ◽  
Endothelial Dysfunction ◽  
Molecular Mechanisms ◽  
Clinical Implications

scholarly journals Renal sodium–glucose transport: role in diabetes mellitus and potential clinical implications

2009 ◽  
Vol 75 (12) ◽  
pp. 1272-1277 ◽  
Author(s):  
George L. Bakris ◽  
Vivian A. Fonseca ◽  
Kumar Sharma ◽  
Ernest M. Wright
Keyword(s):  
Diabetes Mellitus ◽  
Glucose Transport ◽  
Clinical Implications

scholarly journals Gestational diabetes mellitus affects placental iron homeostasis: Mechanism and clinical implications

2020 ◽  
Vol 34 (6) ◽  
pp. 7311-7329
Author(s):  
Jonas Zaugg ◽  
Hassan Melhem ◽  
Xiao Huang ◽  
Malgorzata Wegner ◽  
Marc Baumann ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Iron Homeostasis ◽  
Clinical Implications ◽  
Homeostasis Mechanism

scholarly journals Gestational Diabetes Mellitus: a review of the diagnosis, clinical implications and management

2013 ◽  
Vol 4 (2) ◽  
pp. 127-139
Author(s):  
Vincent Wing-Ming Wong
Keyword(s):  
Diabetes Mellitus ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Management Strategies ◽  
Nutrition Therapy ◽  
Clinical Implications ◽  
The Future ◽  
Medical Nutrition

Gestational diabetes mellitus (GDM) is a condition that affects the wellbeing of mother and fetus. Women with GDM are at risk of type 2 diabetes mellitus in the future, while fetal exposure to hyperglycaemia in-utero may affect their glycometabolic profile later in life. Appropriate screening and management of this problem is important in ensuring good pregnancy outcomes. In this review, the clinical implications, the various ways to screen and diagnose GDM, and management strategies during pregnancy will be discussed. For years, insulin is the mainstay of treatment if medical nutrition therapy fails to maintain adequate glycaemic control, but use of other oral pharmacotherapy may gain greater acceptance in the future. Following delivery, ongoing follow-up of these women is worthwhile as early intervention through lifestyle or pharmacotherapy may prevent the development of diabetes.

Sign in / Sign up

Export Citation Format

Share Document